Abstract:Objective:To investigate the effect of Roux-en-Y gastric bypass (RYGB) on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetes mellitus (T2DM) rats.Methods:A total of 16 Sprague-Dawley male rats were fed on a high-fat diet and injected intraperitoneally with streptozotocin to induce T2DM, then all rats were randomly divided into sham surgery group ( n=8) and RYGB group ( n=8). RYGB surgery was performed in RYGB group, sham surgeries involved the same gastrointestinal transections as those in the RYGB group, and re-anastomosis was performed at the same sites. Fasting blood glucose levels and food intake were measured before and 1st, 2nd, 4th, 6th, 8th week after surgery. Oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed preoperatively and at 2nd and 8th week postoperatively. At 8th week postoperatively, the fasting serum bile acids levels were measured and hepatic tissues were taken to compare the mRNA expression of farnesoid X receptor (FXR), small heterodimeric partner (SHP), phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) by reverse transcriptase-polymerase chain reaction. Results:At 4th, 6th, 8th week postoperatively, the food intake in RYGB group [(18±2), (19±3), (20±4) g/d] was decreased as compared with sham surgery group [(24±3), (28±4), (26±3) g/d]; At 2nd, 4th, 6th and 8th week postoperatively, the fasting blood glucose levels in RYGB group [(6.9±0.9), (6.0±1.1), (6.4±0.8), (6.8±0.7) mmol/L] were decreased as compared with sham surgery group [(12.9±1.4), (10.8±0.8), (9.4±1.1), (9.0±1.0) mmol/L], with significant differences ( t=4.707, 5.091, 3.394, 9.209, 9.982, 6.239, 5.098, P<0.05); On postoperative week 2, the areas under the curve of OGTT and ITT in RYGB group [(898±118), (428±85) mmol/ (L·min)] were decreased compared with sham surgery group [(1 508±108), (788±98) mmol/ (L·min)]; On postoperative week 8, the areas under the curve of OGTT and ITT in RYGB group [(975±102), (455±76) mmol/ (L·min) ] were decreased as compared with sham surgery group [(1 575±96), (775±86) mmol/ (L·min) ], with significant differences ( t=10.790, 7.849, 12.120, 7.886, P<0.05); On postoperative week 8, the serum total bile acids level in RYGB group [(105.17±14.81) μmol/L] was increased as compared with sham surgery group [(68.87±10.81) μmol/L], with significant differences ( t=5.600, P<0.05); As compared with sham surgery group, the hepatic mRNA expression of FXR and SHP in RYGB group was up-regulated (1.67±0.31 vs. 1.17±0.11, 2.37±0.21 vs. 1.33±0.18), the hepatic mRNA expression of PEPCK and G6Pase in RYGB group was down-regulated (0.77±0.12 vs. 1.15±0.14, 0.87±0.08 vs. 1.05±0.10), with significant differences ( t=4.299, 10.640, 5.829, 3.976, P<0.05). Conclusion:RYGB can improve the glucose metabolism in T2DM rats, which may be related with increased hepatic bile acids signaling and decreased gluconeogenesis.

Dual effect of RYGB on the entero-insular axis: How GLP-1 is enhanced by surgical duodenal exclusion

Roux-en-Y Gastric Bypass-Induced Improvement of Glucose Tolerance and Insulin Resistance in Type 2 Diabetic Rats Are Mediated by Glucagon-Like Peptide-1

Roux-en-Y Gastric Bypass Compared to Equivalent Diet Restriction: Mechanistic Insights into Diabetes Remission.

Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.

Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats

Contribution of Endogenous Glucagon-Like Peptide-1 to Changes in Glucose Metabolism and Islet Function in People with Type 2 Diabetes Four Weeks after Roux-en-Y Gastric Bypass (RYGB).

Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice

RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine

Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.

Gastric Inhibitory Polypeptide (GIP) is Selectively Decreased in the Roux-Limb of Dietary Obese Mice after RYGB Surgery

GLP-1 Receptor Signaling is Not Required for Reduced Body Weight after RYGB in Rodents.

In vivo mapping of postprandial hepatic glucose metabolism using dynamic magnetic resonance spectroscopy combined with stable isotope flux analysis in Roux‐en‐Y gastric bypass adults and non‐operated controls: A case–control study

Effect of Roux-en-Y Gastric Bypass Surgery on Hepatic Glucolipid Metabolism in Rats with Obesity Combined with Type 2 Diabetes Mellitus

Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet

RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves?

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass

Effect of Roux-en-Y gastric bypass on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetic rats

Roux-en-Y Gastric Bypass Improved Insulin Resistance Via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia

Gastric Bypass Surgery Alters the Mechanisms of Insulin Resistance in the Adipose Tissue of Gk Rats

Roux-en-Y gastric bypass potentially improved intestinal permeability by regulating gut innate immunity in diet-induced obese mice

Changes of Serum Lipopolysaccharide, Inflammatory Factors, and Cecal Microbiota in Obese Rats with Type 2 Diabetes Induced by Roux-en-Y Gastric Bypass